Stockreport

ArriVent Announces a Multi-Target ADC Collaboration with Alphamab

ArriVent BioPharma, Inc.  (AVBP) 
PDF Collaboration will leverage Alphamab’s antibody drug conjugate (“ADC”) research and discovery platform and ArriVent’s global development and commercialization expertise [Read more]